One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The WFN Service page
Wolfgang Grisold, Steven Lewis
doi : 10.1016/j.jns.2024.123037
Volume 462, 15 July 2024, 123037
Structural network topology associated with naming improvements following intensive aphasia therapy in post-stroke aphasia
Trevor A. Low a, Matthew J. Chilvers a, Harold Zhu a, Helen L. Carlson a b c d, Ashley D. Harris c d e, Bradley G. Goodyear a c e, Sean P. Dukelow a c f
doi : 10.1016/j.jns.2024.123065
Volume 462, 15 July 2024, 123065
Spinal cord MRI activity in multiple sclerosis: Predictive value for relapses and impact on treatment decisions
L. Lorefice a, C. Piras a, V. Sechi b, M.A. Barracciu b, E. Cocco a, G. Fenu c
doi : 10.1016/j.jns.2024.123057
Volume 462, 15 July 2024, 123057
Effects and safety of high-frequency rTMS in subacute ischemic stroke patients
Teppei Komatsu a, Takuya Hada b, Nobuyuki Sasaki c, Hiroyuki Kida a, Takahiro Maku a, Ryoji Nakada a, Tomomichi Kitagawa a, Takeo Sato a, Hiroki Takatsu a, Kenichi Sakuta a, Kenichiro Sakai a, Tadashi Umehara a, Hidetaka Mitsumura a, Masahiro Abo b, Yasuyuki Iguchi a
doi : 10.1016/j.jns.2024.123069
Volume 462, 15 July 2024, 123069
Usefulness of magnetic resonance imaging in differentiation between status epilepticus and acute ischemic stroke
Namiko Matsumoto a, Toshihide Ogawa b, Kensaku Shibazaki c, Nozomi Hishikawa a, Yosuke Wakutani a, Yoshiki Takao a
doi : 10.1016/j.jns.2024.123066
Volume 462, 15 July 2024, 123066
Nodding syndrome: A role for environmental biotoxins that dysregulate MECP2 expression?
Peter S. Spencer a b c, Raquel Valdes Angues a, Valerie S. Palmer a c
doi : 10.1016/j.jns.2024.123077
Volume 462, 15 July 2024, 123077
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing
A. Manni a, F. Oggiano a, C. Palazzo a, V. Panetta b, C.D. Gargano a, V. Mangialardi a, T. Guerra a, A. Iaffaldano a, F. Caputo a, P. Iaffaldano a, M. Ruggieri a, M. Trojano a, D. Paolicelli a
doi : 10.1016/j.jns.2024.123070
Volume 462, 15 July 2024, 123070
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases
Lorenzo Barba a, Giovanni Bellomo b, Patrick Oeckl c d, Davide Chiasserini e, Lorenzo Gaetani b, Edoardo Guido Torrigiani b, Federico Paolini Paoletti b, Petra Steinacker a, Samir Abu-Rumeileh a, Lucilla Parnetti b 1, Markus Otto a 1
doi : 10.1016/j.jns.2024.123059
Volume 462, 15 July 2024, 123059
A novel tool for characterising upper limb function in progressive multiple sclerosis through kinematic assessment
Linford Fernandes a, Rachel O. Coats b, Mark Mon-Williams b, Awais Hafeez c, Raymond Holt c, Helen L. Ford a
doi : 10.1016/j.jns.2024.123068
Volume 462, 15 July 2024, 123068
White matter integrity and functional connectivity of the default mode network in acute stroke are associated with cognitive outcome three months post-stroke
Viktoria Fruhwirth a b c, Lisa Berger d, Thomas Gattringer a e, Simon Fandler-Höfler a, Markus Kneihsl a, Sebastian Eppinger a, Stefan Ropele a, Andreas Fink c, Hannes Deutschmann e, Gernot Reishofer e, Christian Enzinger a b e, Daniela Pinter a b
doi : 10.1016/j.jns.2024.123071
Volume 462, 15 July 2024, 123071
In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study
Yanyan Kong a, Lei Cao a b, Jiao Wang c, Junyi Zhuang c, Fang Xie a, Chuantao Zuo a, Qi Huang a, Kuangyu Shi d, Axel Rominger d, Ming Li a, Ping Wu a, Yihui Guan a, Ruiqing Ni b d e
doi : 10.1016/j.jns.2024.123079
Volume 462, 15 July 2024, 123079
Stroke associated with sarcoidosis: A systematic review of reported cases
Danielle Kei A. Pua a c, Pria Anand b, Shamik Bhattacharyya a c
doi : 10.1016/j.jns.2024.123080
Volume 462, 15 July 2024, 123080
Outcomes and differences by occluded vessel after endovascular thrombectomy for isolated medium vessel occlusions
Hidetoshi Matsukawa a b, Kazutaka Uchida a b c, Conor Cunningham b, Mohammad-Mahdi Sowlat a, Sameh Samir Elawady a, Ilko Maier d, Pascal Jabbour e, Joon-Tae Kim f, Stacey Quintero Wolfe g, Ansaar Rai h, Robert M. Starke i, Marios-Nikos Psychogios j, Amir Shaban k, Adam Arthur l, Hugo Cuellar m, Brian M. Howard n, Ali Alawieh o, Daniele G. Romano p, Omar Tanweer q, Justin Mascitelli r…Shinichi Yoshimura b
doi : 10.1016/j.jns.2024.123054
Volume 462, 15 July 2024, 123054
Evaluation of the T25FW in minimally disabled people with multiple sclerosis
Birgit Helmlinger a b, Daniela Pinter a b, Stefanie Hechenberger a b, Gerhard Bachmaier c, Michael Khalil b d, Bettina Heschl b, Anna Damulina b, Alexander Pichler b, Christian Enzinger a b
doi : 10.1016/j.jns.2024.123073
Volume 462, 15 July 2024, 123073
Multimodal imaging analyses in neuromyelitis optica spectrum disorder with or without visual disturbance
Moto Nakaya a b, Noriko Sato a, Fumio Suzuki a b, Norihide Maikusa a, Hiroshi Matsuda a c, Yukio Kimura a, Yoko Shigemoto a, Emiko Chiba a, Miho Ota a d, Takashi Yamamura e, Wakiro Sato e, Tomoko Okamoto f, Osamu Abe b
doi : 10.1016/j.jns.2024.123090
Volume 462, 15 July 2024, 123090
Unraveling sex differences in Parkinson's disease through explainable machine learning
Gianfrancesco Angelini a, Antonio Malvaso b c, Aurelia Schirripa c, Francesca Campione c, Sebastian Luca D'Addario c d, Nicola Toschi a e, Daniele Caligiore c f
doi : 10.1016/j.jns.2024.123091
Volume 462, 15 July 2024, 123091
Perceptions of digital technology use for monitoring health in people living with neurological disorders
Katie Reid a, Emily Beswick b c d, Johnny Tam b c d, Alexander Symonds b, Dawn Lyle b c d, Judy Newton b c d, David Perry b, Jonathan Neale b, Siddharthan Chandran b c d e, Suvankar Pal b c d
doi : 10.1016/j.jns.2024.123072
Volume 462, 15 July 2024, 123072
Mapping lower-limbs muscle vulnerability in patients with ALS: The role of upper and lower motor neurons
Giammarco Milella a, Stefano Zoccolella b c, Alessia Giugno c, Marco Filardi a c, Eustachio D'Errico a, Glauco Piccirilli a, Alfredo Gabriele Nanni a, Daniele Urso c, Salvatore Nigro c, Benedetta Tafuri a c, Ludovica Tamburrino a c, Valentina Gnoni c, Giancarlo Logroscino a c
doi : 10.1016/j.jns.2024.123098
Volume 462, 15 July 2024, 123098
Development and validation of the DBS-PS (Deep Brain Stimulation-Perception Scale): Assessing parkinsonian patients' expectations to prevent post-operative disappointment?
Mylène Meyer a, Elisabeth Spitz b, Sophie Colnat-Coulbois c, Isabelle Benatru d, Dominique Guehl e, Elodie Hainque f, Anne-Sophie Rolland g, Jean-Christophe Corvol f, Hervé Devilliers h, Raymund Schwan i j, David Devos g k, for the PREDISTIM group
doi : 10.1016/j.jns.2024.123093
Volume 462, 15 July 2024, 123093
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
Edgar Carnero Contentti a, Pablo A. Lopez a, Juan Pablo Pettinicchi a, Jimena Miguez b, Liliana Patrucco c, Edgardo Cristiano c, Susana Liwacki d e, Verónica Tkachuk f, MarÃa E. Balbuena f, Carlos Vrech g, Norma Deri h, Jorge Correale i, Mariano Marrodan i, MarÃa C. Ysrraelit i, Felisa Leguizamon j, Geraldine Luetic k, DarÃo Tavolini l, Carolina Mainella m, Gisela Zanga n, Marcos Burgos o…Juan I. Rojas c u
doi : 10.1016/j.jns.2024.123099
Volume 462, 15 July 2024, 123099
21st century accelerating neurological deaths in UK and major Western countries: - Demographic and/or multiple-interactive-environmental causes?
Colin Pritchard, Anne Silk, Lars Hansen, Harpal Panesar, Therese Berendt
doi : 10.1016/j.jns.2024.123094
Volume 462, 15 July 2024, 123094
An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1
Joost Kools a, Nicol Voermans a, John G. Jiang b, Olga Mitelman b, Michelle L. Mellion b, Vivekananda Ramana b, Baziel G.M. van Engelen a
doi : 10.1016/j.jns.2024.123096
Volume 462, 15 July 2024, 123096
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
Angelo Pascarella a b, Lucia Manzo a b, Sara Gasparini a b, Oreste Marsico a b, Domenico Abelardo a b, Claudia Torino c, Vittoria Cianci b, Alfonso Iudice d, Francesca Bisulli e f, Paolo Bonanni g, Emanuele Caggia h, Alfredo D'Aniello i, Carlo Di Bonaventura j, Jacopo C. DiFrancesco k, Elisabetta Domina l, Fedele Dono m, Antonio Gambardella a n, Francesco Fortunato a n, Carla Marini o, Alfonso Marrelli p…Edoardo Ferlazzo a b
doi : 10.1016/j.jns.2024.123106
Volume 462, 15 July 2024, 123106
Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis
Toshiki Fukasawa a b, Etsuro Nakanishi c, Hiroo Shimoda d, Katsumi Shinoda d, Satoru Ito d e, Shinji Asada d, Satomi Yoshida a, Sachiko Tanaka-Mizuno a b, Kayoko Mizuno a b, Ryosuke Takahashi c, Koji Kawakami a
doi : 10.1016/j.jns.2024.123092
Volume 462, 15 July 2024, 123092
Comparison of functional and safety outcomes between the extended versus early time window after intravenous thrombolysis and endovascular thrombectomy
Laura Mannismäki, Nicolas Martinez-Majander, Olli Suomalainen, Gerli Sibolt, Maria Girfanova, Miranda Nybondas, Hanna Nissinen, Sami Curtze
doi : 10.1016/j.jns.2024.123107
Volume 462, 15 July 2024, 123107
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
A.A. Toorop a, M.H.J. Wessels a, L.M.Y. Gelissen a, E. Hoitsma b, E.M.P.E. Zeinstra c, L.C. van Rooij d, C.E.P. van Munster e, A. Vennegoor f, J.P. Mostert g, B.H.A. Wokke h, N.F. Kalkers i, E.L.J. Hoogervorst j, J.J.J. van Eijk k, C.M. Roosendaal l, J.J. Kragt m, M. Eurelings n, J. van Genugten o, J. Nielsen p, L.G.F. Sinnige q, M.E. Kloosterziel r…Z.L.E. van Kempen a
doi : 10.1016/j.jns.2024.123102
Volume 462, 15 July 2024, 123102
Nailfold capillary measurements correlated to NOTCH3 R544C mutation in preclinical CADASIL patients
Chun-Min Liang a 1, Wei Lee a 1, Chien-Chih Chou a b c d, Hsin Tung a e f, Hung-Chieh Chen d g, Hsian-Min Chen h, Wei-Ju Lee a f i j, Yi-Ming Chen a d k l m n
doi : 10.1016/j.jns.2024.123109
Volume 462, 15 July 2024, 123109
Development and implementation of a case-based collaborative learning flipped classroom preclinical neurology course
Aaron L. Berkowitz a, Bernard S. Chang b c
doi : 10.1016/j.jns.2024.123097
Volume 462, 15 July 2024, 123097
Cortex-to-caudate volume ratio as a predictor of cognitive decline in Alzheimer's disease and mild cognitive impairment
Seunghee Na a, Taewon Kim a, In-Uk Song a, Yun Jeong Hong b, Seong-Hoon Kim b
doi : 10.1016/j.jns.2024.123113
Volume 462, 15 July 2024, 123113
Lack of inflammation or immune response in cyst tissue of patients with symptomatic non-hydrocephalic pineal cysts
César Luis Vera Quesada a b, Shreyas Balachandra Rao c, Reidun Torp c, Pitt Niehusmann d, Per Kristian Eide a b e
doi : 10.1016/j.jns.2024.123111
Volume 462, 15 July 2024, 123111
Futile recanalization is associated with increased risk of post-stroke epilepsy
Simona Lattanzi a b, Claudia Cuccurullo c, Niccolò Orlandi d e, Giuseppe Borzì d f, Guido Bigliardi d f, Stefania Maffei d f, Giada Giovannini d, Stefano Meletti d e
doi : 10.1016/j.jns.2024.123067
Volume 462, 15 July 2024, 123067
Validating the efficacy and risks of endovascular thrombectomy in large ischemic strokes: Insights from a trial sequential analysis
Amanda Cyntia Lima Fonseca Rodrigues
doi : 10.1016/j.jns.2024.123064
Volume 462, 15 July 2024, 123064
Trial sequential analysis of the efficacy of off-hour mechanical thrombectomy in acute ischemic stroke: Have we generated enough evidence in the field?
Amanda Cyntia Lima Fonseca Rodrigues
doi : 10.1016/j.jns.2024.123075
Volume 462, 15 July 2024, 123075
Correspondence on ‘Trial sequential analysis of the efficacy of off hour mechanical thrombectomy in acute ischemic stroke: Have we generated enough evidence in the field?’
Sherief Ghozy a b, David F. Kallmes a
doi : 10.1016/j.jns.2024.123076
Volume 462, 15 July 2024, 123076
Outcome measures for hereditary spastic paraplegia clinical trials: Learnings from an Australian HSP center
Sue Faye Siow a b c, Amy Waters d, Sharon Coward d, Gautam Wali b c g, Karl Ng b d, Carolyn M. Sue c g h, Kishore R. Kumar b e f
doi : 10.1016/j.jns.2024.123100
Volume 462, 15 July 2024, 123100
Response to letter to editor ‘comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement’
Noriko Nishikawa a, Takayuki Ishida b, Taku Hatano a, Nobutaka Hattori a
doi : 10.1016/j.jns.2024.123101
Volume 462, 15 July 2024, 123101
Comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement
Daniel Matovu
doi : 10.1016/j.jns.2024.123103
Volume 462, 15 July 2024, 123103
The need for careful consideration of futile recanalization in acute ischemic stroke patients undergoing endovascular treatment
Helen Shen a b 1, Sonu M.M. Bhaskar a b c d e f
doi : 10.1016/j.jns.2024.123104
Volume 462, 15 July 2024, 123104
Response to letter to the editor: “The need for careful consideration of futile recanalization in acute ischemic stroke patients undergoing endovascular treatment�
Simona Lattanzi a, Stefano Meletti b c
doi : 10.1016/j.jns.2024.123105
Volume 462, 15 July 2024, 123105
